Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

Luz M Canet¹, Jose M Sánchez-Maldonado¹, Rafael Cáliz^{1

2}, Ana Rodríguez-Ramos¹, Carmen B Lupiañez¹, Helena Canhão³, Manuel Martínez-Bueno⁴, Alejandro Escudero⁵, Juana Segura-Catena¹, Signe B Sorensen^{6

7}, Merete L Hetland^{6

7}, María José Soto-Pino², Miguel A Ferrer², Antonio García², Bente Glintborg^{6

8}, Ileana Filipescu⁹, Eva Pérez-Pampin¹⁰, Alfonso González-Utrilla², Miguel Ángel López Nevot¹¹, Pablo Conesa-Zamora¹², Alfons den Broeder¹³, Salvatore De Vita¹⁴, Sven Erik Hobe Jacobsen^{6

7}, Eduardo Collantes-Estevez⁵, Luca Quartuccio¹⁴, Federico Canzian¹⁵, João E Fonseca^{16

17}, Marieke J H Coenen¹³, Vibeke Andersen^{18

19}, Juan Sainz^{20

21}

Affiliations

¹ Genomic Oncology Area, GENYO Centre for Genomics and Oncological Research, Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.
² Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain.
³ CEDOC, EpiDoC Unit, NOVA Medical School and National School of Public Health, Universidade Nova de Lisboa, Lisbon, Portugal.
⁴ Area of Genomic Medicine, GENYO Centre for Genomics and Oncological Research, Pfizer / University of Granada / Andalusian Regional Government, Granada, Spain.
⁵ Rheumatology Department, Reina Sofía Hospital/IMIBIC/University of Córdoba, Córdoba, Spain.
⁶ The Danish Rheumatologic Biobank, the DANBIO Registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark.
⁷ Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Department of Rheumatology, Gentofte and Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
⁹ Rheumatology Department, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.
¹⁰ Rheumatology Unit, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
¹¹ Immunology Department, Virgen de las Nieves University Hospital, Granada, Spain.
¹² Clinical Analysis Department, Santa Lucía University Hospital, Cartagena, Spain.
¹³ Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
¹⁴ Department of Medical and Biological Sciences, Clinic of Rheumatology, University of Udine, Udine, Italy.
¹⁵ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁶ Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.
¹⁷ Rheumatology Research Unit, Faculty of Medicine, Instituto de Medicina Molecular, University of Lisbon, Lisbon Academic Medical Center, Lisbon, Portugal.
¹⁸ Focused Research Unit for Molecular Diagnostic and Clinical Research, IRS-Center Sonderjylland, Hospital of Southern Jutland, DK-6200, Aabenraa, Denmark.
¹⁹ Faculty of Health Sciences, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
²⁰ Genomic Oncology Area, GENYO Centre for Genomics and Oncological Research, Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain. juan.sainz@genyo.es.
²¹ Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain. juan.sainz@genyo.es.

PMID: 30760878
DOI: 10.1038/s41397-019-0084-2

Free article

Published Erratum

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

Luz M Canet et al. Pharmacogenomics J. 2019 Dec.

Free article

. 2019 Dec;19(6):582.

doi: 10.1038/s41397-019-0084-2.

Authors

Affiliations

¹ Genomic Oncology Area, GENYO Centre for Genomics and Oncological Research, Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.
² Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain.
³ CEDOC, EpiDoC Unit, NOVA Medical School and National School of Public Health, Universidade Nova de Lisboa, Lisbon, Portugal.
⁴ Area of Genomic Medicine, GENYO Centre for Genomics and Oncological Research, Pfizer / University of Granada / Andalusian Regional Government, Granada, Spain.
⁵ Rheumatology Department, Reina Sofía Hospital/IMIBIC/University of Córdoba, Córdoba, Spain.
⁶ The Danish Rheumatologic Biobank, the DANBIO Registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark.
⁷ Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Department of Rheumatology, Gentofte and Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
⁹ Rheumatology Department, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.
¹⁰ Rheumatology Unit, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
¹¹ Immunology Department, Virgen de las Nieves University Hospital, Granada, Spain.
¹² Clinical Analysis Department, Santa Lucía University Hospital, Cartagena, Spain.
¹³ Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
¹⁴ Department of Medical and Biological Sciences, Clinic of Rheumatology, University of Udine, Udine, Italy.
¹⁵ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁶ Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.
¹⁷ Rheumatology Research Unit, Faculty of Medicine, Instituto de Medicina Molecular, University of Lisbon, Lisbon Academic Medical Center, Lisbon, Portugal.
¹⁸ Focused Research Unit for Molecular Diagnostic and Clinical Research, IRS-Center Sonderjylland, Hospital of Southern Jutland, DK-6200, Aabenraa, Denmark.
¹⁹ Faculty of Health Sciences, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
²⁰ Genomic Oncology Area, GENYO Centre for Genomics and Oncological Research, Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain. juan.sainz@genyo.es.
²¹ Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain. juan.sainz@genyo.es.

PMID: 30760878
DOI: 10.1038/s41397-019-0084-2

Abstract

The original version of this Article contained an error in the spelling of the author Ana Rodríguez-Ramos, which was incorrectly given as Ana Rodríguez Ramos. This has now been corrected in both the PDF and HTML versions of the Article.

PubMed Disclaimer

Erratum for

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H, Martínez-Bueno M, Escudero A, Segura-Catena J, Sorensen SB, Hetland ML, Soto-Pino MJ, Ferrer MA, García A, Glintborg B, Filipescu I, Pérez-Pampin E, González-Utrilla A, Nevot MÁL, Conesa-Zamora P, Broeder AD, De Vita S, Jacobsen SEH, Collantes-Estevez E, Quartuccio L, Canzian F, Fonseca JE, Coenen MJH, Andersen V, Sainz J. Canet LM, et al. Pharmacogenomics J. 2019 Feb;19(1):83-96. doi: 10.1038/s41397-018-0057-x. Epub 2018 Oct 5. Pharmacogenomics J. 2019. PMID: 30287909

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Andalusian Health Repository - access to free full text
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

Affiliations

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources